- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$206.31 MnMarket Estimate, 2026
$234.57 MnMarket Forecast, 2034
$655.17 MnCAGR, 2026–2034
13.7%Executive Summary: Latin America Digital Breast Tomosynthesis (DBT) Equipment Market
- Market Scope: Regional analysis of Latin America's digital breast tomosynthesis equipment sector, detailing product variations, end-user applications, dense-breast screening benefits, and country-level profiles.
- Market Valuation: Valued at USD 206.31 million in 2025, reaching USD 234.57 million in 2026, and projected to expand to USD 655.17 million by 2034, growing at a robust CAGR of 13.70% from 2026 to 2034.
- Primary Growth Drivers: Rising prevalence of breast cancer across Latin America, increasing screening uptake, technological advancements in novel imaging products, and the clinical advantage of improved detection in dense breasts.
Key Market Segment Metrics
| Category | Leading Segment (Base Position) | Fastest-Growing / High-Growth Segment |
|---|---|---|
| By Product | DBT Equipment (dominated in base year, driven by high diagnostic accuracy and advanced 3D imaging capabilities) | 3-D Upgradation (anticipated at a rapid growth rate, fueled by cost-effective retrofitting of existing conventional mammography units) |
| By End User | Hospitals (captured the major market share, supported by extensive patient volumes, institutional budgets, and comprehensive oncology care) | Diagnostic Centers (projected at the highest growth rate, driven by specialized outpatient screening clinics and faster turnaround times) |
| By Country | Brazil (market leader in the region backed by widespread breast cancer screening initiatives and high survivor populations) | Mexico (key regional hub driven by well-established healthcare infrastructure, rising healthcare spending, and technological advancements) |
Major Market Players & Industry Landscape
Market Structure: Highly consolidated medical imaging landscape featuring key multinational technology providers establishing strong distribution channels and clinical partnerships across Latin America.
Key Companies: Hologic Inc., Siemens Healthineers, Fujifilm Corporation, GE Healthcare, Internazionale Medico Scientifica S.r.l., and Planmed Oy.
Download Free Sample Report
Latin America Digital Breast Tomosynthesis (DBT) Equipment Market Size
The Latin America Digital Breast Tomosynthesis (DBT) Equipment market was valued at USD 206.31 million in 2025, is estimated to reach USD 234.57 million in 2026, and is projected to reach USD 655.17 million by 2034, growing at a CAGR of 13.7% from 2026 to 2034.
Digital breast tomosynthesis is a limited-angle tomography technology that uses X-rays to create a 3-dimensional image of the breast. It is a new technique that aids in identifying breast cancer in its early stages.
Another vital feature is digital breast tomosynthesis, which is particularly beneficial in analyzing dense breasts and can help improve and increase breast cancer detection. It lowers the rate of false-positive results when normal tissue is misidentified as abnormal and eliminates the necessity for a biopsy. It is suitable for any woman, but it is perfect for those with dense breasts.
The rising prevalence of breast cancer would significantly drive the Latin America digital breast tomosynthesis (DBT) Equipment market. According to statistics, women in Mexico will be diagnosed with 268,600 new instances of invasive breast cancer and 62,930 new cases of non-invasive breast cancer in 2019.
Furthermore, more than 150,000 breast cancer survivors in Brazil live with metastatic disease, with three-quarters of them being diagnosed with stage I-III. The rising prevalence of breast cancer in Latin America, raising awareness of the usage of tomosynthesis, and technological improvements in developing new novel imaging products are the primary drivers driving the digital breast tomosynthesis equipment market.
The lack of data on DBT's usefulness is expected to hamper the expansion of the global digital breast tomosynthesis (DBT) Equipment market. There have been no significant trials conducted on DBT. These trials require a large participant pool to show that DBT has a meaningful effect on cancer diagnosis.
The market's growth is also hampered by strict training requirements for radiologists and technicians.
Due to the desire for novel goods, rising screening uptake, and the availability of qualified healthcare professionals in this area, Latin America holds a moderate market share in the worldwide digital breast tomosynthesis (DBT) Equipment market
COUNTRY ANALYSIS
Geographically, the Latin America accounted for 55.1 percent of the global digital breast tomosynthesis (DBT) equipment market in terms of value in 2019. During DBT, patients are exposed to more radiation than during 2D mammography.
The Mexico digital breast tomosynthesis equipment market has major growth due to the female breast cancer accounts for 15% of all new cancer cases. In addition, technical improvements in breast imaging, well-established healthcare infrastructure, and rising healthcare spending contribute to the overall regional market's growth.
The Brazil digital breast tomosynthesis equipment market should expect favorable development prospects as radiation exposure is reduced. In addition, DBT's application in group and individual breast cancer screening and its usage in breast cancer detection and staging multiple lesions may be described by regulatory authorities.
KEY MARKET PLAYERS
Noteworthy Companies leading the Latin America Digital Breast Tomosynthesis (DBT) Equipment Market Profiled in the Report are Hologic Inc., Siemens Healthineers, and Fujifilm Corporation. Other players in the market include GE Healthcare, Internazionale Medico Scientifica S.r.l. and Planmed Oy.,
MARKET SEGMENTATION
This research report on the Latin America Digital Breast Tomosynthesis (DBT) Equipment Market has been segmented and sub-segmented into the following categories
By Product
- 3-D Upgradation
- DBT Equipment
By End User
- Hospitals
- Diagnostic centres
By Country
- Mexico
- Brazil
- Argentina
- Chile
- Rest of Latin America